TuisOMCL • NASDAQ
add
Omnicell Inc
Vorige sluiting
$31,38
Dagwisseling
$31,04 - $32,18
Jaarwisseling
$25,12 - $55,75
Markkapitalisasie
1,46 mjd USD
Gemiddelde volume
620,72 k
P/V-verhouding
115,02
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 306,88 m | 18,56% |
Bedryfskoste | 129,16 m | 8,10% |
Netto inkomste | 15,84 m | 210,21% |
Netto winsgrens | 5,16 | 192,97% |
Wins per aandeel | 0,60 | 81,82% |
EBITDA | 27,93 m | 630,06% |
Effektiewe belastingkoers | 32,87% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 369,20 m | -21,11% |
Totale bates | 2,12 mjd | -4,76% |
Totale aanspreeklikheid | 877,65 m | -15,44% |
Totale ekwiteit | 1,24 mjd | — |
Uitstaande aandele | 46,76 m | — |
Prys om te bespreek | 1,17 | — |
Opbrengs op bates | 1,56% | — |
Opbrengs op kapitaal | 1,98% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 15,84 m | 210,21% |
Kontant van bedrywe | 56,32 m | 46,60% |
Kontant van beleggings | -13,57 m | -9,67% |
Kontant van finansiering | -234,43 m | -1 885,45% |
Netto kontantverandering | -194,28 m | -607,49% |
Beskikbare kontantvloei | 52,06 m | 134,76% |
Meer oor
Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth. Wikipedia
Gestig
Sep. 1992
Webwerf
Werknemers
3 670
